Ask AI

CAR-T Bridging, Sequencing, and Care Coordination Considerations in RRMM

CAR T-cell therapy is transforming outcomes for patients with multiple myeloma (MM), but rapid uptake has also introduced new, high-stakes complexity in day-to-day care. In this downloadable teaching resource, you will find expert-led information regarding hot topics in the practical implementation of CAR T-cell in MM. Topics covered include the rationale for using CAR T-cell in MM, patient selection, current and future considerations for sequencing, bridging strategies, and key adverse event recognition strategies. 

CAR T RRMM Slides

Activity Information

Released: August 17, 2026